BACKGROUND: Evidence of racial disparities in the receipt of postmastectomy breast reconstruction is well documented. The objective of this study was to describe trends in racial disparities overall and by reconstructive technique. METHODS: The American College of Surgeons National Surgical Quality Improvement Program database was used to identify women who underwent mastectomy and/or breast reconstruction from 2005 to 2014. Patient demographics were recorded, and cases were grouped by reconstructive status and technique. Trends were assessed with the Cochran-Armitage test and the index of disparity. RESULTS: Over the study period, 92,960 postmastectomy patients were identified (77,049 white women, 10,396 black women, 4939 Asian women, and 576 Native American women), of whom 46,931 underwent reconstruction. Of these, 7692 women underwent autologous reconstructions (3913 free flaps and 3696 pedicled flaps). From 2005 to 2014, receipt of breast reconstruction by postmastectomy patients rose from 33.2% to 60.0%, receipt of autologous reconstruction by patients who underwent breast reconstruction fell from 30.4% to 15.9%, and receipt of free-flap reconstruction by patients who underwent autologous reconstruction rose from 15.0% to 70.8%. These trends were significant in all racial subgroups (P <.001), except for Native Americans (P 5.269). The index of disparity decreased from 51.4% to 22.6% for overall receipt of breast reconstruction, decreased from 10.7% to 7.0% for tissue expander and implant-based reconstruction, increased from 18.0% to 27.3% for autologous reconstruction, and decreased from 66.7% to 4.3% for free-flap reconstruction. CONCLUSIONS: The use of postmastectomy breast reconstruction is steadily rising in the United States. Racial disparities persist, but progress has been made. Further efforts are needed to reduce racial disparities. Cancer 2018;124:2774-84. V C 2018 American Cancer Society.
INTRODUCTION
Breast cancer has the highest incidence of nonskin malignancy among American women. Approximately 250,000 new breast cancers are diagnosed every year. Death rates from breast cancer have dropped since 1989 because of earlier screening, increased awareness, and better treatments. 1 Currently, there are more than 2.8 million breast cancer survivors in the United States. 1 Many of these patients are eligible for breast reconstruction. Postmastectomy breast reconstruction has been covered by insurers since 1998, when the Women's Health and Cancer Rights Act was passed. 2 Commensurately, the receipt of postmastectomy breast reconstruction has doubled in the last decade, with tissue expander and implantbased (TE/I) reconstruction accounting for >75% of all breast reconstructions. 3 Despite this encouraging trend, racial and socioeconomic disparities in the receipt of postmastectomy breast reconstruction have been well documented. [4] [5] [6] [7] [8] For instance, a review of the National Cancer Data Base from 1998 to 2007 revealed that non-African American race, higher household income, and private or managed care insurance were positive predictors of breast reconstruction. 5 In another study, distance to a plastic surgeon and government-funded health insurance, such as Medicare, were identified as negative predictors of breast reconstruction. 7 These disparities have been attributed to variations in access to care, because they were not observed within the Department of Defense cancer registry, which is an equal-access system. 6 Policies that improve health care access, such as the Women's Health and Cancer Rights Act, have undoubtedly increased the volume of postmastectomy reconstruction. However, this increase disproportionately favors TE/I reconstruction. 9 Autologous reconstruction has been associated with higher patient-reported satisfaction, yet this reconstructive option has been underused. [10] [11] [12] [13] [14] [15] [16] This may be because of poor access to technically specialized surgeons, longer operative and recovery times, and financial constraints. 3, 17, 18 Minority patients are often vulnerable to these constraints. Therefore, they may not have adequate access to all types of reconstructive options. This is concerning even when considering autologous reconstruction alone, because donor site morbidity and abdominal physical well being differ between abdominally based free-flap (eg, deep inferior epigastric artery perforator [DIEP] flap) and pedicled flap (eg, transverse rectus abdominis myocutaneous [TRAM] flap) reconstructions. 19 For instance, compared with TRAM flaps, DIEP flaps have been associated with lower rates of hernia and fat necrosis, shorter hospital stays, superior postoperative pain, and better abdominal contour. [20] [21] [22] However, free-flap reconstructions also are associated with longer operative times and require specialized surgical training (ie, patient candidacy and patient access to specialized surgeons define limits on distributive justice). 19 Furthermore, superiority of 1 technique over another has not been established. 23 Nonetheless, prior cross-sectional studies have identified racial disparities in breast reconstruction technique. 8 Understanding racial disparities in utilization trends by technique may help direct policies aimed at supporting equitable use once the etiology of disparity is determined.
The objective of the current study was to evaluate 1) the trend in racial disparities in the receipt of postmastectomy breast reconstruction overall and 2) trends in racial disparities in the types of breast reconstruction used from 2005 to 2014 in a national database.
MATERIALS AND METHODS
We performed a cross-sectional analysis of data in the American College of Surgeons National Surgery Quality Improvement Program (ACS-NSQIP) database from 2005 to 2014. The ACS-NSQIP is a prospectively maintained, nationally validated, risk-adjusted, outcome-based program that was developed to measure and improve the quality of surgical care. 24, 25 The data are collected by trained researchers at participating institutions, which are mostly larger, more tertiary academic institutions, in 49 states. The patient population results from systematic sampling of adults (aged 18 years) who undergo major procedures performed under general, spinal, or epidural anesthesia. The procedures are defined by Current Procedural Terminology (CPT) codes. The first 40 cases of each included procedure are selected over repeated cycles of 8 days. This sampling mechanism results in about 1600 cases selected per hospital per year, or approximately 70% of all of each institution's major procedures.
We queried the ACS-NSQIP database to identify all female patients who underwent mastectomy and/or breast reconstruction for the years from 2005 through 2014. The unit of analysis was the patient. Patient demographics and select comorbidities were recorded. Age and body mass index (BMI) were coded as continuous variables; year of operation, race, ethnicity, tobacco use, alcohol use, diabetes mellitus (DM), and status of chemotherapy and radiotherapy were coded as categorical variables. CPT codes were used to define patient cohorts by reconstruction status and type. CPT codes queried included 193* codes for mastectomy and reconstruction.
Mastectomies were identified using CPT codes 19303 through 19307 as well as their retired codes (19180, 19182, 19200, 19220, and 19240) , because the analysis spanned years before and after the code change (see Table 1 for full list of CPT codes with accompanying descriptors). TE/I breast reconstructions were identified by CPT codes 19340, 19342, and 19357 . Other breastreconstruction techniques and mixed TE/I and autologous techniques were identified by CPT codes 19366, 19340, 19342, 19357, and 19361 . Autologous reconstructions were identified by CPT codes 19364, 19361, 19367, 19368, and 19369 . Subgroups included free flaps (CPT code 19364), latissimus dorsi muscle flaps (CPT code 19361), and TRAM flaps (CPT codes 19367, 19368, and 19369) . Patients who underwent a latissimus dorsi muscle flap with or without prosthesis were included in the autologous cohort, because the use of a muscle flap was considered a significant component of the reconstruction. Patients who underwent other and mixed forms of reconstruction (eg, TE/I and autologous) were excluded from the autologous cohort; the few patients who underwent mixed forms of autologous reconstruction (eg, TRAM and latissimus dorsi flaps) likewise were excluded from the autologous cohort to preserve subgroup fidelity.
Receipt of an autologous procedure was assessed for trends over time and by racial cohort both on its own and in the context of overall breast reconstruction use. Each variable was assessed for normality using graphic and statistical (eg, skewness, kurtosis) methods. Results of the normality assessment guided our bivariate analysis methods. Trends in utilization rates for overall breast reconstruction, autologous reconstruction, and free-flap reconstruction for the years 2005 to 2014 were determined using the Cochran-Armitage test for trend. This analysis was conducted for each racial cohort to determine whether utilization trends differed by race. Trends in racial disparities were assessed using the index of disparity (ID isp ), which was introduced by Pearcy and Keppel in 2002 to assess for disparities in a diverse range of health indicators, including health services utilization. 26 The measure can be used to understand disparities in crosssectional analyses and to monitor trends in disparities over time. It has since been described as a legitimate method for calculating inequality in health care utilization by the Surveillance Research Program and Applied Research Program of the Division of Cancer Control and Population Sciences of the National Cancer Institute, National Institutes of Health. 27, 28 It has been used by several scholars in original research articles 29, 30 ; and it has been used in original research articles published in peer-reviewed journals. 31 The ID isp is a measure that summarizes the difference between several racial group utilization rates and a reference rate and then expresses the summed differences as a proportion of the reference rate. 19 Mathematically,
where r j indicates the breast reconstruction utilization rate in the jth group, r ref represents the rate among the reference population, and J is the number of groups compared. We chose white patients as our reference group, because this group frequently had the best rate and was the largest group in the study. Finally, a multivariable logistic regression model was built to determine which factors were independently associated with the use of free-flap reconstruction. Covariables in the regression were chosen a priori based on a literature review. Previous analyses have identified several variables that are significantly associated with breast-reconstruction technique. These include age, BMI, tobacco use, radiotherapy, chemotherapy, and DM. 8, 32, 33 Studies have assessed the relation between these factors and breast-reconstruction technique. Radiotherapy is particularly well studied.
Several studies have assessed the relation between radiotherapy and TE/I versus autologous reconstruction. 34 The American Society of Plastic Surgeons recommends that patients who choose TE/I reconstruction in the setting of radiotherapy should be carefully counseled on the risk of complications, such as reconstructive failure. 35 Consequently, some surgeons recommend that patients consider autologous reconstruction when radiotherapy is involved in their breast cancer management. 34 For autologous reconstruction, evidence of an association between these factors and TRAM flap versus DIEP flap reconstruction is inconsistent. 23 One study assessing the relation between radiation therapy and type of free-flap reconstruction reported no significant differences in complications. 36 Women of color present with more severe disease and may be more likely to require radiotherapy for management. Given the important relation between radiotherapy and TE/I compared with autologous reconstruction and the growing study of the relation between radiotherapy and types of autologous reconstruction, we only included patients who had complete data for both race and radiotherapy in the regression analysis.
All statistical tests were 2-sided, and a was set at .05. A Bonferroni-Holm correction for multiple comparisons was applied to the bivariate analysis; as such, statistical significance for 11 comparisons was defined as a naive P value < .004. R version 3.3.2 was used for all statistical analyses (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS

Descriptive Analysis
Over the study period, 92,960 postmastectomy patients were identified, of whom 46,931 (50.5%) underwent breast reconstruction ( Table 4) .
Multivariable Analysis
On multivariable analysis, race was not identified as an independent predictor of the odds of undergoing free-flap breast reconstruction (Table 5 ). Age and tobacco use were associated with decreased odds of undergoing free-flap breast reconstruction (odds ratio, 0.98 and 0.68, respectively; P < .001 and P 5 .005, respectively). Other covariables, including BMI, Hispanic ethnicity, DM, and radiotherapy, were not significant (P > .05). The predictors chemotherapy and alcohol were excluded because of large amounts of missing data. Interaction terms for race and radiotherapy and for race and BMI were explored but did not significantly add to the model.
Trend Analysis
Over a period of 10 years (2005 to 2014), the proportion of postmastectomy patients receiving breast reconstruction increased from 33.2% to 60.0% (Fig. 1A) , the proportion of autologous reconstructions fell from 30.8% to 16.1% (Fig. 1B) , and the proportion of autologous flaps that were free flaps rose from 14.6% to 71.4% (Fig. 1C) . These trends were significant in all racial subgroups (P < .001) except for American Indians and Alaska Natives, for whom no trend was statistically significant (P 5 .269) (Figs. 1-3 ). Despite the significant increase in overall breast reconstruction utilization among postmastectomy patients of most racial groups, disparities between racial groups were still apparent in 2014, with a higher utilization rate among white patients. In 2014, the difference in the overall breast reconstruction utilization rate between white and black patients was 8.17%, the difference between white and Asian patients was 14.77%, and the difference between white and Native American patients was 19.03% ( Fig. 2A) . Racial disparities were observed for autologous and free-flap utilization as well, with minority breast reconstruction patients undergoing autologous reconstruction more than white patients (Fig.  2B) , and white autologous breast reconstruction patients using free-flap reconstruction more than minority patients (Fig. 2C) . The index of racial disparity decreased from 51.4% to 22.6% (difference between the rate in 2005 and the rate in 2014 (D) 5 28.8%) for overall receipt of breast reconstruction, decreased from 10.7% to 7.0% (D 5 3.7%) for receipt of TE/I breast reconstruction, increased from 18.0% to 27.3% (D 5 9.3%) for receipt of autologous breast reconstruction, and decreased from 66.7% to 4.3% (D 5 62.3%) for receipt of free-flap breast reconstruction (Fig. 3) .
DISCUSSION
The results from this study indicate that the receipt of postmastectomy breast reconstruction steadily increased These observations may be related to changes in public health policy. Since passage of the Women's Health and Cancer Rights Act in 1998, coverage for postmastectomy breast reconstruction has been secured in both public and private insurance sectors. 37 Since passage of the Patient Protection and Affordable Care Act in 2010, many patients have improved access to health care like breast cancer screening. 38 The increase in overall breast reconstruction utilization and the reduction in racial disparities that we observed in this study may be subsequent to these efforts to improve health equity. This may be why we observed a steady, gradual decline in disparities for most of the study period, before a more abrupt decline in 2012 (Fig. 3) . However, despite this encouraging progress, racial inequities persist. The ID isp for breast reconstruction utilization can still improve by 22.6%.
These findings indicate that having access to care does not always result in receipt of care. The National Healthcare Quality Report 2011 described 3 steps in achieving good access to care: 1) access to the health care system (ie, insurance), 2) access to sites of care where patients can receive services (ie, availability of hospitals and clinics within an accessible distance), and 3) access to providers with whom patients can develop a relationship based on open communication and trust. 39 Although many patients may have access to care through insurance and mandated breast reconstruction coverage, there are socioeconomic barriers that disproportionately prevent nonwhite patients from truly accessing care. These include the financial burden of health care costs, timely access to care, literacy and language barriers, and the availability of trustworthy providers to whom patients can relate. High premiums and out-of-pocket payments can deter patients from obtaining necessary medical care, especially when options are costly and time-intensive. 40 For instance, multiple studies have reported delayed oncologic treatment for black and Hispanic patients as well as for women with Medicare. 41, 42 Our results indicate that further progress can be made in racial disparities within reconstructive techniques, particularly autologous reconstruction (ID isp 5 27.3% for autologous reconstruction, 7.0% for TE/I reconstruction, and 4.3% for free-flap reconstruction) (Fig. 3) . Among patients undergoing breast reconstruction, more black and Native American patients received autologous reconstruction ( Fig. 2B) . Of all patients undergoing autologous reconstruction, less minority patients underwent free-flap reconstruction (Fig. 2C) . These findings are likely caused by many patient, provider, and systemic factors. Autologous reconstruction may be more common among minority patients because of more severe disease, necessitating more aggressive treatment that may include radiation therapy. 43 Social epidemiologists have elucidated how the minority patient's milieu affects the likelihood of aggressive breast cancer and downstream consequences in reconstructive options even before birth. 43 The significant disparities in free-flap reconstruction identified on multivariable analysis are likely a result of pooling the data over the study period, because the ID isp for free-flap reconstruction started out very high (66.7% in 2005) and remained high through 2010, after which it was greatly reduced (5.2%) (Fig. 3) . This progress may be associated with the increasing attention to racial disparities in the plastic surgery literature that occurred over the study period. Nonetheless, a small amount of racial disparity persists in the receipt of freeflap reconstruction (4.3%).
Remaining disparities in free-flap reconstruction may be associated with patient, provider, and systemic factors. The longer hospitalization, longer time away from work, longer operative time, and the higher possibility of short-term complications associated with free-flap reconstruction may disproportionately deter socioeconomically disadvantaged patients. There also may be fewer providers with microsurgery training and fewer hospitals with microsurgical equipment, meaning that patients interested in autologous reconstruction may need to travel farther for care. This theory has been elaborated in a regional study of the North Carolina Cancer Registry, in which distance to a plastic surgeon and government-sponsored insurance were independent negative predictors of autologous reconstruction. 7 Providers may consciously or unconsciously be inclined to recommend TE/I over autologous reconstruction because of lower reimbursement for more labor-intensive procedures. 9, 44 A study of the National Inpatient Database from 1998 to 2008 indicated that a decline in the autologous reconstruction rate paralleled that of Medicare reimbursement for this procedure. 18 A national survey of 312 plastic surgeons indicated that the majority of plastic surgeons believed that breast reconstruction is rewarding, but many were decreasing their practice because of perceived poor reimbursement and lack of resident coverage. 28 This sentiment disproportionately affects Medicaid patients, because the Medicaid reimbursement rate is at least 25% less than that of other payers. 17 Compared with TE/I, autologous reconstruction reportedly produces superior patient-reported outcomes. [10] [11] [12] [13] [14] [15] [16] However, TE/I reconstruction has expanded more than autologous reconstruction. TE/I reconstruction had less racial disparities compared with autologous reconstruction. This may reflect the finding that TE/I reconstruction is a common choice among women who have less aggressive, earlier stage breast cancer that does not require radiation therapy.
This study builds on work demonstrating that current federal and state policies are not enough to fully resolve racial disparities in the receipt of postmastectomy breast reconstruction. 45 In addition to enacting public health policies that target more upstream socioeconomic determinants, current legislation targeting downstream factors should be accompanied by workforce redistribution strategies, improved reimbursement for complex surgical procedures, and tools to aid patient decision making, such as social work and medical literature of an appropriate health literacy level. Future directions should include updating this analysis once the Patient Protection and Affordable Care Act has been fully implemented for at least 1 year and conducting more granular studies aimed at assessing specific health policies. Other studies to consider include comparing the results of this analysis with results from a study that uses a different national database and conducting a closer analysis of patient and provider decision making to determine the etiology of the differences observed in the use of TE/I versus with autologous reconstruction.
The strengths of this study include its large sample size and many pertinent variables available for an adjusted analysis. However, with the many strengths of large database research come several limitations. Although there are ACS-NSQIP-participating hospitals in 49 states, the database is not a comprehensive, nationally representative sample. Furthermore, ACS-NSQIP data do not provide weights that allow for standardization over time and across diverse hospital characteristics (eg, size, volume, type [academic vs community], urbanicity, geographic regions). This means that the sampling strategy may render results that reflect more on the database than on national utilization rates and trends. This was demonstrated in a study comparing rates of immediate breast reconstruction among 3 national databases in which the investigators observed that the ACS-NSQIP overestimated rates of breast reconstruction compared with the Nationwide Inpatient Sample and the Surveillance, Epidemiology, and End Results Program from the Healthcare Cost and Utilization Project and the National Cancer Institute, respectively. 46 Thus, the rates reported in this study are likely to be inflated and may underestimate some utilization disparities. Nonetheless, assessing trends in the ACS-NSQIP sample renders important information on many of the largest institutions in the United States, and several groups have published reports in the peer-reviewed literature on ACS-NSQIP utilization trends. [47] [48] [49] Another limitation is that ACS-NSQIP data are not longitudinal. Thus, we made the assumption that patients undergoing delayed breast reconstruction were also captured as patients undergoing mastectomy without immediate breast reconstruction. We assumed that unpaired mastectomy cases were patients who did not undergo reconstruction, when these patients may have undergone reconstruction at a non-ACS-NSQIPparticipating hospital. Likewise, patients undergoing delayed reconstruction may have undergone mastectomy at a non-ACS-NSQIP-participating hospital. In a recent study, Tseng and colleagues observed that, of 623 women who chose not to receive immediate postmastectomy breast reconstruction, only 8% later underwent delayed reconstruction. 50 If many patients underwent mastectomy at a non-ACS-NSQIP-participating hospital but underwent reconstruction at an ACS-NSQIP-participating hospital, then the reconstruction rate would be artificially inflated
Original Article in the current study. However, we agreed that most patients likely received most of their care at participating or nonparticipating institutions and did not cross over frequently enough to significantly affect our data and conclusions.
Finally, the study years included a change in categorization of race and ethnicity, which required collapse of groups with distinct differences. For instance, Asians and Pacific Islanders were collapsed into a single group. Furthermore, although some categories included more than 1 distinct group of people, for some subgroup analyses, the sample size was too small to render significant results. For instance, the small sample size of American Indians and Alaska Natives precluded statistically significant results for analyzing utilization trends.
Despite these limitations, this study provides new and important information. Future study should include conducting this analysis using Healthcare Cost and Utilization Project/Nationwide Inpatient Sample and National Cancer Institute/Surveillance, Epidemiology, and End Results Program for comparison.
Conclusion
Postmastectomy breast reconstruction utilization is steadily rising in the United States. Racial disparities persist, although progress has been made. Disparities are multifactorial in etiology. A comprehensive approach to preventing nonpatient-selection factors from playing a role in the patient's reconstructive decision-making process might include legislative changes, improved patient education and counseling, superior interdepartmental collaboration to address socioeconomic determinants, workforce redistribution, physician sensitivity training, and better financial compensation for more complex surgical procedures. Further research is needed to evaluate these approaches to reducing racial disparities in the receipt of breast reconstruction.
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